Dr.Reddy's: Dr Reddy's launches drug for neck, head cancer
Dr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This drug is for treating recurrent or metastatic nasopharyngeal carcinoma. It will be marketed under the name Zytorvi. Before this, the standard treatment was chemotherapy with gemcitabine and cisplatin.
Read full article »
Dr.Reddy's is an India-based pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates for for the healthcare sector.
Read more